Epidemiology : Norwalk
is a town in Ohio, USA where the virus was 1st isolated. Human caliciviruses
(HuCVs) are reportedly responsible for 2.5-4% of nonbacterial sporadic
gastroenteritis; each year NLV affects around 23 million people and kills
300 in the US alone in military camps, hospitals, schools, universities,
picnics, ....; norovirus infection on cruise ships is introduced usually
by passengers and/or crew and ships could be successfully decontaminated
both during and between voyages. The high-density conditions on cruise
ships provide a suitable environment for the spread of norovirus infection.
Consequently cruise ships can be considered sensitive indicators of the
prevalence of norovirus infection in the general population. Some notable
outbreaks of viral gastroenteritis on US-based ships :
-
1986 : outbreaks (392 passengers and 30 crew, in 2 outbreaks) were reported
during 2 one-week Caribbean ship cruises; norovirus infection was presumed
with source not established.
-
1994 (publication year) : an outbreak (217 cases) of norovirus infection
aboard a cruise ship in Hawaii was traced to contaminated ice.
-
1995 (publication year) - An outbreak (585 cases, approximate) was reported
aboard an aircraft carrier.
-
1997 : an outbreak (450 cases reported; true number estimated at 1806)
of probable NA infection occurred on an American aircraft carrier off the
coast of Japan in 1997, source unknown.
-
1999 : outbreaks (587 cases total; 162 + 425 cases) were reported among
military ships following port visits in Southeast Asia.
-
2001 : a total of 7 outbreaks were reported on cruise ships.
-
2002 : outbreaks (2098 cases in 24 outbreaks) affecting 18 ships were reported.
These figures included a Disney cruise ship in Florida (2 outbreaks encompassing
approximately 185 cases).
-
2002 : an outbreak (300 cases) was reported aboard an aircraft carrier.
-
2002 : an outbreak (250 or more cases) of norovirus infection affected
over 250 passengers on a cruise ship in Alaska, source unknown. A 2nd outbreak
(218 cases) occurred on the same cruise ship 2 weeks later, and a 3rd outbreak
(183 cases) the following month.
-
2003 : an outbreak (247 cases) was reported on a cruise ship from Los Angeles
to Hawaii.
-
2003 : an outbreak (150 cases) was reported on a cruise ship in New Orleans.
-
2003 : an outbreak (340 cases) was reported on a north Atlantic cruise
ship.
-
2004 : an outbreak (39 cases) of suspected norovirus infection was reported
on a cruise ship in the Caribbean.
-
2004 : an outbreak (116 cases) of norovirus infection was reported on a
cruise ship to the Caribbean.
-
2005 : an outbreak (94 cases) of norovirus infection was reported on a
cruise ship from Florida to the Caribbean.
-
2006 : suspected norovirus outbreak affecting a Caribbean cruise ship
It is notable that these outbreaks have occurred on board civilian and
naval ships with high complements of passengers and/or crew members and
making frequent landfalls, which no doubt increase the probability of introduction
and spread of agents responsible for rapid-onset gastroenteritis. The reason
you hear about norovirus on cruise ships is because they are required to
report every incidence of gastrointestinal illness : nowhere else in the
public health system of the USA is norovirus a reportable illness, excepted
the State of Idaho.
Norovirus is the most common cause of infectious intestinal disease
(IID) in England
ref.
The number of outbreaks of IID due to norovirus varies, but is generally
between 130 to 250 outbreaks each year. 2 distinct peaks of norovirus activity
have occurred in England and Wales since 1992: one in 1995-96 with 368
outbreaks, and, in 2002, there was an unusually high number of outbreaks
(686) that coincided with the emergence of a new variant GGII
ref.
79% of all outbreaks reported have occurred in healthcare settings, either
in hospitals or residential care homes. Hotels (7%) and schools (5%) are
the next most frequent settings. Outbreaks in the healthcare sector show
a marked seasonality, with peak occurrence in the winter months, although
other settings do not appear to show this seasonal pattern. Outbreaks in
healthcare settings are also associated with higher rates of mortality
and last longer than outbreaks in other settings, but tend to involve fewer
people and are less likely to be foodborne
ref.
A recent study in the South West of England examining the impact of IID
outbreaks in healthcare settings showed norovirus to be the predominant
cause and was identified in 63% of outbreaks. The cost to the health service
in England was estimated to be GBP 115 million [USD 214 million], after
extrapolating the cost of bed days lost plus staff absence. Outbreaks were
seen to be shorter when control measures were implemented quickly, such
as closing wards to new admissions within 4 days of the beginning of the
outbreak
ref.
The genetic distances between the animal and human NLVs are similar to
the distances between the
GGI and
GGII strains, and epidemic
spread of some NLV strains led to the widespread (possibly global) emergence
of a single predominant strain in the human population in 1995-96, the
"95/96-US" strain. New variants of the norovirus tend to appear once every
5 years : the old ones die away as people build up immunity to them. In
England and Wales, 614 outbreaks were reported in 2002 - a 77% increase
on the previous peak of 347 outbreaks in 1995. Unusually, many outbreaks
occurred during the summer. Similar increases were noted in many other
countries, including Hungary, Germany and Denmark. 2002's problems included
a new variant called
GII4. Norovirus is currently on the rise in
Virginia and several other American states. It is unclear if the culprit
is the same GII4 variant or not.
-
recombinant noroviruses : genetic recombination, first described
for poliovirus and foot-and-mouth disease virus, is probably an attribute
of all small positive-sense RNA viruses maintaining genetic diversity.
The detection of recombinants in the unrelated outbreaks described below
suggests that genetic recombination may play a role in the etiology of
epidemic gastroenteritis, possibly contributing to evasion of the immune
response.
-
responsible for gastroenteritis outbreaks in New South Wales, Australia,
in recent times have been identifiedref1,
ref2.
Norovirus (NoV) genogroups I and II (GI and GII) are now recognized as
the predominant worldwide cause of outbreaks of acute gastroenteritis in
humans. 3 recombinant NoV GII isolates were identified and characterized,
2 of which are unrelated to any previously published recombinant NoV. Using
data from the current study, published sequences, database searches, and
molecular techniques, 23 recombinant NoV GII and 1 recombinant NoV GI isolates
were identified. Analysis of the genetic relationships among the recombinant
NoV GII isolates identified 9 independent recombinant sequences; the other
14 strains were close relatives. 2 of the 9 independent recombinant
NoV were closely related to other recombinants only in the polymerase region,
and in a similar fashion one recombinant NoV was closely related to another
only in the capsid region. Breakpoint analysis of recombinant NoV showed
that recombination occurred in the open reading frame (ORF)1/ORF2 overlap.
Evidence was provided to support the theory of the role of subgenomic RNA
promoters as recombination hotspots and describe a simple mechanism of
how recombination might occur in NoV. The aims of this study were to characterize
and compare 3 recombinant NoV sequences isolated in Sydney with other published
recombinant NoV and those identified through database searches and phylogenetic
analysis. The genetic relationship among all identified recombinants was
explored and the recombination breakpoint accurately determined. A model
of NoV recombination is proposed. The authors also concluded that decline
in the prevalence of previously dominant strains, such as US-95/96 in the
USA and Australia, suggests immunity in the community might be an important
factor in reducing further spread of NoV. Recombination offers NoV an attractive
mechanism for immune evasion. Subgenomic RNA promoters have been proposed
to be recombination hotspots. Noroviruses are thought to be one of the
reasons for a 5-fold increase in infectious gastroenteritis cases in the
period 2000 - 2003ref.
Noroviruses cause up to 90% of infectious gastroenteritis cases globally
each year. In 2004 there were well over 10,000 NSW cases of infectious
gastroenteritis. Outbreaks in recent years were reported at a Sydney children's
hospital (February 2002), a Sydney aged care facility (September, 2002),
a Picton aged care facility (July 2003) and in Wagga Wagga (October 2003)ref.
-
Hungary : between Jan 2001 and Dec 2003, stool specimens from 262 (45%)
of 581 reported outbreaks of gastroenteritis were investigated for noroviruses.
Specimens collected from outbreaks of non-bacterial gastroenteritis were
examined by RT-PCR and enzyme immunoassay. In 253 (97%) of 262 outbreaks,
norovirus was detected and confirmed by sequencing in 211 (81%). Hospitals
(35%), day care centers (30%), and elderly homes (27%) were the most common
settings. Diversity and frequency of the genotypes changed over time but
with predominance (95%) of genogroup (GG) II strains. Strains grouped into
11 genotypes including an epidemic spread of new-variant GGII4 (Lordsdale
virus) and a recently emerged group of natural recombinant strains (GGIIb/Hilversum
polymerase) with 4 capsid types (Hawaii, Mexico, Snow Mountain, and Lordsdale).
Clusters of epidemics including food-borne outbreaks were detected.
The known host range of noroviruses is also greater than previously thought
with novel strains recently identified in mice, cows, pigs and humans.
However, human norovirus research is hindered by the lack of a cell
culture system and a small animal model of infection. Norwalk virus (NV)
is the prototype strain of human noroviruses. The successful replication
of NV viral RNA and its packaging into virus particles in mammalian cells
by intracellular expression of native forms of NV viral RNA devoid of extraneous
nucleotide sequences derived from the expression vector, by the use of
replication-deficient vaccinia virus MVA encoding the bacteriophage T7
RNA polymerase (MVA/T7), was reported in 2005. Expressed genomic RNA was
found to replicate; NV subgenomic RNA was transcribed from genomic RNA
by use of NV nonstructural proteins expressed from genomic RNA and was
subsequently translated into NV capsid protein VP1. Viral genomic RNA was
packaged into virus particles generated in mammalian cells. The cesium
chloride (CsCl) density gradient profile of virus particles containing
genomic RNA was similar to that of NV purified from stool. These observations
indicate that the NV cDNA constructed here is a biologically infectious
clone, and that mammalian cells have the ability to replicate NV genomic
RNA. This work establishes a mammalian cell-based system for analysis of
human norovirus replication and, thus, makes it feasible to investigate
antiviral agents in mammalian cells
ref.
Genomics : sequence alignment of norovirus
GGII4 lineages: GGII4 cons is the consensus sequence of strains prevalent
before 2002, GGII4 2002 is the consensus sequence of the strain that was
dominant in the 2002/2003 winter season, GGII4 2004 is the consensus sequence
of the strain that has become dominant during 2004. The sequence is from
the RNA dependent RNA polymerase gene, the region upstream of the conserved
YGDD motif. 11 informative positions in the alignment have been highlighted
with an asterisk above the sequence. In these positions, one sequence is
different from the other 2.
....*....| ....|....| ....|....* ....|....|
10 20
30 40
GGII4 cons CAGCCCTAGA AATCATGGTT AAATTCTCCT CAGAACCACA
GGII4 2002 CAGCTCTAGA AATCATGGTT AAATTCTCCT CAGAACCACA
GGII4 2004 CAGCTCTAGA AATCATGGTT AAATTCTCCC CAGAACCACA
....|....| ....|....| ....|....| ....|....|
50 60
70 80
GGII4 cons TTTGGCTCAG GTAGTCGCAG AAGACCTTCT TTCTCCTAGC
GGII4 2002 TTTGGCTCAG GTAGTCGCAG AAGACCTTCT TTCTCCTAGC
GGII4 2004 TTTGGCTCAG GTAGTCGCAG AAGACCTTCT TTCTCCTAGC
....|...*| ....|....| ..*.|....| ....|*...|
90 100
110 120
GGII4 cons GTGGTGGATG TGGGTGACTT CAAAATATCA ATCAATGAGG
GGII4 2002 GTGGTGGATG TGGGTGACTT CACAATATCA ATCAACGAGG
GGII4 2004 GTGGTGGACG TGGGTGACTT CACAATATCA ATCAACGAGG
....*....| ....|.*..| ....|....| ....|....|
130 140
150 160
GGII4 cons GTCTCCCCTC TGGGGTGCCC TGCACCTCCC AATGGAACTC
GGII4 2002 GTCTCCCCTC TGGGGTACCC TGCACCTCCC AATGGAACTC
GGII4 2004 GTCTTCCCTC TGGGGTGCCC TGCACCTCCC AATGGAACTC
....|....| ....|....| ....|....| ....|....|
170 180
190 200
GGII4 cons CATCGCCCAC TGGCTTCTCA CTCTCTGTGC GCTCTCTGAA
GGII4 2002 CATCGCCCAC TGGCTTCTCA CTCTCTGTGC GCTCTCTGAA
GGII4 2004 CATCGCCCAC TGGCTTCTCA CTCTCTGTGC GCTCTCTGAA
....|...** ....*....| ..*.|....| ....|....|
210 220
230 240
GGII4 cons GTTACAAACT TGTCCCCTGA CATCATACAG GCTAATTCCC
GGII4 2002 GTTACAAATC TGTCCCCTGA CATCATACAG GCTAATTCCC
GGII4 2004 GTTACAAACT TGTCTCCTGA CACCATACAG GCTAATTCCC
ref1,
ref2,
ref3
Resistance : innate genetic resistance
mediated by inactive
a(1,2)fucosyltransferase
gene (FUT2) alleles and acquired immunity characterized by rapid Norwalk
virus-specific mucosal IgA production in some secretor (Se
+)
volunteers are both dose-independent resistance mechanisms. Norovirus-like
particles bind more efficiently to O and A antigens than to B-antigen saliva
specimens : supporting a prior study, group-O individuals were more susceptible
to Norwalk virus infection than group A or B individuals.
Transmission : an inoculum of as few as
10 viral particles is enough to infect an individual
-
oro-faecal (via contaminated food or surfaces)
-
inhalation (with subsequent ingestion) of aerosolized viral particles where
exposure to vomiting
was high (sharing toilet facilities and restrooms)ref1,
ref2,ref3;
asymptomatic cases have been reported to have helped spread outbreaksref;
the difficulty of controlling person-to-person spread has been documented,
especially if symptoms include vomitingref
Pathogenesis :
murine
norovirus 1 (MNV-1) infects macrophage-like cells
in vivo and
replicates in cultured primary dendritic cells and macrophages
ref
=>
acute gastroenteritis
("
winter vomiting
disease") : after 16-48 hours incubation =>
nausea
and vomiting
,
diarrhea
and
fever
lasting 12-48 hours.
Laboratory examinations : human noroviruses
cannot be propagated in cell-culture systems which complicates analysis.
However, expression of recombinant VP1 in insect cells results in the formation
of virus-like particles (VLPs). An antibody ELISA using polyclonal antisera
raised against these VLPs has been used to determine cross-reactivity.
Considerable antigenic diversity was detected. Antisera reacted strongly
with homologous VLPs; however, a number of novel cross-reactivities among
different genotypes was noted. For example, GI/11 antiserum showed a broad-range
cross-reactivity, detecting 2 GI and 10 GII genotypes. Likewise, GII/1,
GII/10 and GII/12 antisera showed a broad-range cross-reactivity, detecting
several other distinct GII genotypes
ref
Prevention :
-
isolation of affected persons
-
use of gloves and facial masks while cleaning contaminated areas;
-
cleaning of contaminated areas with disinfectants containing 1000-5000
ppm of hypochlorite, carpets with steam (other suggest the use of hypochlorite
at 1000 ppm for disinfectionref,
recent reports do suggest that this concentration may be too low for efficient
inactivation of noroviruses, and levels of 3000 to 5000 ppm free chlorine
may be more appropriateref1,
ref2
-
washing of contaminated bed linen at least at 70°C using detergents
preferably with bleach
-
particular attention to door handles, taps, toilet or bath rails
-
frequent hand washing
-
no return to work until 48-72 hours after compete resolution of symptoms
for affected staff, and education on virus shedding which may continue
for weeks.
Experimental animal models : human strains
cannot be grown in many lab animals or cells. Scientists have resorted
to filtering the virus from diarrhoea - and feeding it to human volunteers;
STAT1
-dependent
innate immunity, but not T and B cell-dependent adaptive immunity, is essential
for resistance to murine norovirus 1 infection in mice (which anyway do
not suffer gastrointestinal problems)
ref
Web resources :